Abstract
The lymph spread of the rectal cancer is various according to the tumor location. Pathways of lymphatic drainage are dived into three groups, the upper two thirds of the rectum, dentate line up to the lower third of the rectum, and the anal canal up to dentate line. Lymph node metastasis from rectal cancer usually occurs in regional rectal lymph nodes that consist of three groups: perirectal, intermediate and main lymph nodes, and lateral pelvic lymph nodes. The concept of total mesorectal excision is equally accepted in the West and East, but the role of lateral pelvic lymph node dissection is accepted differently. Therefore, recently selective pelvic lymph node dissection after preoperative chemoradiotherapy was proposed. Moreover, whole-mount sections or fat clearance techniques have been performed for the precise pathologic assessment after surgery. The lymph node metastasis of rectal cancer progresses differently under various conditions, so the management of rectal cancer should consider various aspects through multidisciplinary team approach.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Dujovny N, Quiros RM, Saclarides TJ. Anorectal anatomy and embryology. Surg Oncol Clin N Am. 2014;13:277–93.
Bell S, Sasaki J, Sinclair G, Chapuis PH, Bokey EL. Understanding the anatomy of lymphatic drainage and the use of blue-dye mapping to determine the extent of lymphadenectomy in rectal cancer surgery: unresolved issues. Color Dis. 2009;11:443–9.
Blair JB, Holyoke A. A note on the lymphatics of the middle and lower rectum and anus. Anat Rec. 1950;108:635–43.
Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery-the clue to pelvic recurrence? Br J Surg. 1982;69:613–6.
Nakamura T, Watanabe M. Lateral lymph node dissection for lower rectal cancer. World J Surg. 2013;37:1808–13.
Montori A, Miscusi G, Saracca L, et al. Transrectal sonography and endoscopic lymphoscintigraphy in the preoperative staging of rectal cancer. Dig Surg. 1984;1:200–4.
Arnaud JP, Bergamaschi R, Schloegel M, Ollier JC, Haegele P, Grob JC, Adloff M. Progress in the assessment of lymphatic spread in rectal cancer. Rectal endoscopic lymphoscintigraphy. Dis Colon Rectum. 1990;33:398–401.
Grinnell RS. The lymphatic and venous spread of carcinoma of rectum. Ann Surg. 1942;116:200–16.
Hida J, Yasutomi M, Maruyama T. Lymph node metastases detected in the mesorectum distal to carcinoma of the rectum by the clearing method: justification of total mesorectal excision. J Am Coll Surg. 1997;184:584–8.
Williams NS, Dixon MF, Johnston D. Reappraisal of the 5 centimetre rule of distal excision for carcinoma of the rectum: a study of distal intramural spread and of patients’ survival. Br J Surg. 1987;70:150–4.
Yao Y-F, Wang L, Liu Y-Q, Li J-Y, Gu J. Lympn node distribution and pattern of metastases in the mesorectum following total mesorectal excision using the modified fat clearing technique. J Clin Pathol. 2011; 64:1073–7.
Cserni G, Tarjan M, Bori R. Distance of lymph nodes from the tumor, an important feature in colorectal cancer specimens. Arch Pathol Lab Med. 2001;125:246–9.
Japanese Society for Cancer of the Colon and Rectum. Japanese classification of colorectal carcinoma, 2nd ed. (English). Tokyo: Kanehara; 2009.
Korean Clinical Practice Guideline for Colon and Rectal Cancer v.1.0. Ivy Plan, Korean Medical Association, Seoul; 2012.
Ishihara S, Kawai K, Tanaka T, Kiyomatsu T, Hata K, Nozawa H, Morikawa T, Watanabe T. Oncological outcomes of lateral pelvic lymph node metastasis in rectal cancer treated with preoperative chemoradiotherapy. Dis Colon Rectum. 2017;60:469–76.
Akiyoshi T, Ueno M, Matsueda K, Konishi T, Fujimoto Y, et al. Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging. Ann Surg Oncol. 2014;21:189–96.
Mori T, Takahashi K, Yasuno M. Radical resection with autonomic nerve preservation and lymph node dissection techniques in lower rectal cancer surgery and its results: the impact of lateral lymph node dissection. Langenbeck’s Arch Surg. 1998;383:409–15.
Moriya Y, Sugihara K, Akasu T, Fujita S. Importance of extended lymphadenectomy with lateral node dissection for advanced lower rectal cancer. World J Surg. 1997;21:728–32.
Ueno M, Oya M, Azekuru K, Yamaguchi T, Muto T. Incidence and prognostic significance of lateral lymph node metastasis in patients with advanced low rectal cancer. Br J Surg. 2005;92:756–63.
Kusters M, Beets GL, van de Velde CJ, et al. A comparison between the treatment of low rectal cancer in Japan and the Netherlands, focusing on the patterns of local recurrence. Ann Surg. 2009;10:1053–62.
Sauer I, Bacon HE. A new approach of excision of carcinoma of the lower portion of the rectum and anal canal. Surg Gynecol Obstet. 1952;95:229–42.
Takahashi T, Ueno M, Azekura K, Ota H. The lymphatic spread of rectal cancer and the effect of dissection: Japanese contribution and experience. In: des Soreide O, Norstein J, editors. Rectal Cancer surgery. Optimisation standardisation documentation. Berlin: Springer-Verlag; 1997. p. 165–80.
Georgiou P, Tan E, Gouvas N, Antoniou A, Brown G, Nicholls RJ, Tekkis P. Extended lymphadenectomy versus conventional surgery for rectal cancer: a meta-analysis. Lancet Oncol. 2009;10:1053–62.
Fujita S, Akasu T, Mizusawa J, Saito N, et al. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomized controlled, non-inferiority trial. Lancet Oncol. 2012;13:616–21.
Saito S, Fujita S, Mizusawa J, Kanemitsu Y, Saito N, et al. Male sexual dysfunction after rectal cancer surgery: results of a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for patients with lower rectal cancer: Japan Clinical Oncology Group Study JCOG0212. Eur J Surg Oncol. 2016;42:1851–8.
Fujita S, Mizusawa J, Kanemitsu Y, Ito M, et al. Mesorectal excision with or without lateral lymph node dissection for clinical stage II/III lower rectal cancer (JCOG0212): a multicenter, randomized controlled, noninferiority trial. Ann Surg. 2017;266:201–7.
Kim TH, Jeong SY, CHoi DH, et al. Lateral lymph node metastasis is a mjor cause of locoregional recurrence in rectal cancer treated with preoperative chemoradiotherapy and curative resection. Ann Surg Oncol. 2008;15:729–37.
Oh HK, Kang SB, Lee SM, Lee SY, Ihn MH, Kim DW, Park JH, Kim YH, Lee KH, Kim JS, Kim JW, Kim JH, Chang TY, Park SC, Sohn DK, Oh JH, Park JW, Ryoo SB, Jeong SY, Park KJ. Neoadjuvant chemoradiotherapy affects the indications for lateral pelvic node dissection in mid/low rectal cancer with clinically suspected lateral node involvement: a multicenter retrospective cohort study. Ann Surg Oncol. 2014;21:2280–7.
Kim MJ, Kim TH, Kim DY, Kim SY, Baek JY, Chang HJ, Park SC, Park JW, Oh JH. Can chemoradiation allow for omission of lateral pelvic node dissection for locally advanced rectal cancer? J Surg Oncol. 2015;111:459–64.
Kwon TS, Choi SB, Lee YS, Kim J-G, Oh ST, Lee IK. Novel methods of lymph node evaluation for predicting the prognosis of colorectal cancer patients with inadequate lymph node harvest. Cancer Res Treat. 2016;48:216–24.
Herrera-Ornelas L, Justiniano J, Castillo N, et al. Metastases in small lymph nodes from colon cancer. Arch Surg. 1987;122:1253–6.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Lee, I.K. (2018). The Lymphatic Spread of the Rectal Cancer. In: Kim, N., Sugihara, K., Liang, JT. (eds) Surgical Treatment of Colorectal Cancer. Springer, Singapore. https://doi.org/10.1007/978-981-10-5143-2_5
Download citation
DOI: https://doi.org/10.1007/978-981-10-5143-2_5
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-5142-5
Online ISBN: 978-981-10-5143-2
eBook Packages: MedicineMedicine (R0)